This work is licensed under a Creative Commons Attribution 4.0 International License.
SST-02
General Information
DRACP ID DRACP00636
Peptide Name SST-02
Sequence RFwKTW
Sequence Length 6
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Cancer targeted peptides
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | IC50>100 μM | MTT assay | 48h | 1 |
| PC-3 | Prostate carcinoma | Carcinoma | IC50>100 μM | MTT assay | 48h | 1 |
| HT-29 | Colon adenocarcinoma | Carcinoma | IC50>100 μM | MTT assay | 48h | 1 |
Hemolytic Activity Human red blood cells: no hemolytic activity(as show in Fig.4)
Normal (non-cancerous) Cytotoxicity HUVEC: IC50>100 μM
Target pigment epithelium-derived factor; somatostatin
Affinity Not available
Mechanism Not available
Nature Anticancer; Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification w=D-Tryptophane
Chiral Mix
Physicochemical Information
Formula C36H50N10O6
Absent amino acids ACDEGHILMNPQSVY
Common amino acids FKRTW
Mass 80821
Pl 11.65
Basic residues 2
Acidic residues 0
Hydrophobic residues 2
Net charge 2
Boman Index -1773
Hydrophobicity -120
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 5500
Absorbance 280nm 1100
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 27734947
Title Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy
Year 2016
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.